@article{JTD21393,
author = {Hui Li and Gening Jiang and Servet Bölükbas and Chun Chen and Haiquan Chen and Keneng Chen and Jun Chen and Xiangli Cui and Wentao Fang and Shugeng Gao and Sebastien Gilbert and Jianhua Fu and Xiangning Fu and Yasuhiro Hida and Shanqing Li and Xiaofei Li and Yin Li and Hecheng Li and Yongjun Li and Deruo Liu and Lunxu Liu and Jianxing He and Jie He and Giuseppe Marulli and Hiroyuki Oizumi and Marc de Perrot and René Horsleben Petersen and Yaron Shargall and Alan Sihoe and Qunyou Tan and Qun Wang and Shun Xu and Mei Yang and Yuanhua Yang and Zhentao Yu and Lanjun Zhang and Xun Zhang and Heng Zhao and Xiuyi Zhi},
title = {The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {5},
year = {2018},
keywords = {},
abstract = {Cancer is an independent major risk factor for venous thromboembolism (VTE), which is the second leading cause of death in medically and surgically treated patients with cancer (1-5). The association between VTE and lung cancer has been reported more than 20 years ago (6,7).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21393}
}